pacing and clinical electrophysiology. 27 (1): 4–9. doi:10.1111/j.1540-8159.2004.00378.x. pmid 14720148. s2cid 24329905. lifevest zoll. "zoll lifevest wearable defibrillator". zoll.com. retrieved march 12, 2023. "premarket approval (pma)". fda. "regulatory approval for lifevest". zoll.com. "clinical research & results". zoll.com. retrieved 2022-08-13. "premarket approval (pma) p010030". fda. retrieved 2022-08-13. "wcd 2000 system" (pdf). fda. 2001-12-18. retrieved 2022-08-13. "summary of safety and effectiveness p010030 lifecor wcd 2000 system" (pdf). fda. retrieved 2022-08-13. "zoll lifevest wearable defibrillator to be showcased at great wall international congress of cardiology 2015". zoll.com. 2015-10-27. retrieved 2022-08-13. "working mechanisms of the lifevest". zoll.com. kutyifa, v (2015). "use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the prospective registry of patients using the wearable cardioverter defibrillator (wearit-ii registry)". circulation. 132 (17): 1613–9. doi:10.1161/circulationaha.115.015677. pmid 26316618. s2cid 207574412. reek, s (2003). "clinical efficacy of a wearable defibrillator in acutely terminating episodes of ventricular fibrillation using biphasic shocks". pacing and clinical electrophysiology. 26 (10): 2016–2022. doi:10.1046/j.1460-9592.2003.00311.x. pmid 14516344. s2cid 206172656. kutyifa, v (2018). "one-year follow-up of the prospective registry of patients using the wearable defibrillator (wearit-ii registry)". pacing and clinical electrophysiology. 41 (10): 1307–13. doi:10.1111/pace.13448. pmid 29992590. s2cid 51615314. marenco, jp (2001). "improving survival from sudden cardiac arrest: the role of the automated external defibrillator". clinical cardiology. 285: 1193–1200. ammannaya, gkk (2020). "implantable cardioverter defibrillators – the past, present and future". archives of medical science – atherosclerotic diseases. 5: e163-170. doi:10.5114/amsad.2020.97103. pmc 7433784. pmid 32832716. atwater, bd (2012). "implantable cardioverter defibrillators: risks accompany the life-saving benefits". heart. 98 (10): 764–772. doi:10.1136/heartjnl-2012-301853. pmid 22422588. s2cid 20583690. sperzel, j (2016). "value of the wearable cardioverter defibrillator (wcd) as a bridging-therapy before implantation of a cardioverter defibrillator (icd)". journal of atrial fibrillation. 8: 93–98. lackermair, k (2018). "impairment of quality of life among patients with wearable cardioverter defibrillator therapy (lifevestd): a preliminary study". biomed research international: 6. weiss, m (2019). "anxiety, depression and quality of life in acute high risk cardiac disease patients eligible for wearable cardioverter defibrillator: results from the prospective multicenter cred- registry". plos one. 14 (3): e0213261. bibcode:2019ploso..1413261w. doi:10.1371/journal.pone.0213261. pmc 6411111. pmid 30856204. mandrola, m.d., john (august 5, 2013). "lifevest: a precarious and unproven bridge . . . to somewhere". www.medscape.com (registration required). retrieved 2018-04-12. commissioner, office of the. "safety alerts for human medical products - zoll lifevest 4000 wearable cardioverter defibrillator: fda safety communication - potential lack of treatment (shock) delivery due to device failure". www.fda.gov. archived from the original on 2020-06-16. retrieved 2018-04-12. "class 2 device recall lifevest wearable defibrillator". www.accessdata.fda.gov. retrieved 2018-04-12. erath, julia; kutiyfa, valentina; assmus, birgit; burch, ashley; bondermann, diana; russo, andrea m. (2019-03-12). "sustained ventricular tachyarrhythmia termination in a large cohort of women with wearable cardioverter defibrillator". journal of the american college of cardiology. acc.19: the american college of cardiology 68th annual scientific sessions. 73 (9): 483. doi:10.1016/s0735-1097(19)31091-5. s2cid 86680926. retrieved 2020-05-06. al-khatib, sm (2018). "2017 aha/acc/hrs guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death". journal of the american college of cardiology. 72 (14): e91–e220. doi:10.1016/j.jacc.2017.10.054. pmid 29097296. s2cid 6725956. piccini, jp (2016). "wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a science advisory from the american heart association". circulation. 133 (17): 1715–1727. doi:10.1161/cir.0000000000000394. pmid 27022063. s2cid 31733718. priori, sg (2015). "2015 esc guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death". europace. 17: 1601–1687. mcdonagh, ta (2021). "2021 esc guidelines for the diagnosis and treatment of acute and chronic heart failure". european heart journal. 42 (36): 3599–3726. doi:10.1093/eurheartj/ehab368. pmid 34447992. gronda, e (2006). "heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: international society for heart and lung transplantation guidelines for the care of cardiac transplant candidates—2006". the journal of heart and lung transplantation. 25 (9): 1043–56. doi:10.1016/j.healun.2006.06.005. pmid 16962465. mehra, mr (2006). "rationale and process: international society for heart and lung transplantation guidelines for the care of cardiac transplant candidates". the journal of heart and lung transplantation. 25 (9): 1001–2. doi:10.1016/j.healun.2006.06.006. pmid 16962462. bowers, roberts (2014). "use of external defibrillator jacket to facilitate safe delivery of radiotherapy for lung cancer e a report of two cases". indian heart journal. 66 (1): 111–114. doi:10.1016/j.ihj.2013.12.004. pmc 4054845. pmid 24581107. nguyen, e (2018). "wearable cardioverter-defibrillators for the prevention of sudden cardiac death: a meta-analysis". the journal of innovations in cardiac rhythm management. 9 (5): 3151–3162. doi:10.19102/icrm.2018.090506. pmc 7252786. pmid 32477809. masri, a (2019). "wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death". jacc: clinical electrophysiology. 5 (2): 152–161. doi:10.1016/j.jacep.2018.11.011. pmc 6383782. pmid 30784684. olgin, je (2018). "wearable cardioverter–defibrillator after myocardial infarction". new england journal of medicine. 379 (13): 1205–1215. doi:10.1056/nejmoa1800781. pmc 6276371. pmid 30280654. s2cid 205102984. olgin, je (2020). "impact of wearable cardioverter-defibrillator compliance on outcomes in the vest trial: as-treated and per-protocol analyses". journal of cardiovascular electrophysiology. 31 (5): 1009–1018. doi:10.1111/jce.14404. pmc 9374026. pmid 32083365. olgin, je (2018). "wearable cardioverter–defibrillator after myocardial infarction". new england journal of medicine. 379 (13): 1205–1215. doi:10.1056/nejmoa1800781. pmc 6276371. pmid 30280654. olgin, je (2020). "impact of wearable cardioverter-defibrillator compliance on outcomes in the vest trial: as-treated and per-protocol analyses". journal of cardiovascular electrophysiology. 31 (5): 1009–1018. doi:10.1111/jce.14404. pmc 9374026. pmid 32083365. aidelsburger, p (2020). "effectiveness, efficacy, and safety of wearable cardioverter-defibrillators in the treatment of sudden cardiac arrest - results from a health technology assessment". international journal of technology assessments in health care. 36 (4): 363–371. doi:10.1017/s0266462320000379. pmid 32600490. s2cid 220270202. cortesi, pa (2021). "health technology assessment on the use of the wearable cardioverter defibillator in patients with myocardial infarction and with icd explant". famreconomia. 22: 3–54. cortesi, pa (2021). "health technology assessment on the use of the wearable cardioverter defibillator in patients with myocardial infarction and with icd explant". famreconomia. 22: 3–54.